Sprague–Dawley rats display metabolism-mediated sex differences in the acute toxicity of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy)

2008/02/20 by Julien Fonsart, Marie‐Claude Menet, Marie-Claude Menet +7 · 34 citations
Chemistry · Medicine · Neuroscience · Pharmacology, Toxicology and Pharmaceutics · #Acute toxicity #Biology #Cannabis and Cannabinoid Research #Chemistry #Designer drug #Drug #Ecstasy #Forensic Toxicology and Drug Analysis #Hallucinogen #Internal medicine #MDMA #Medicine #Metabolism #Neurotransmitter Receptor Influence on Behavior #Pharmacology #Psychiatry #Toxicity #Toxicology

paper · doi:10.1016/j.taap.2008.02.004

published in Toxicology and Applied Pharmacology 230(1), 117-125 (Elsevier BV)

openalex publication_date 2008/02/20 · openalex created_date 2025/10/10 · openalex updated_date 2026/07/29

Citations

• The Pharmacology and Clinical Pharmacology of 3,4-Methylenedioxymethamphetamine (MDMA, “Ecstasy”)
• Systematic risk behavior of financially distressed firms

Cited by

• Female rats display dose-dependent differences to the rewarding and aversive effects of nicotine in an age-, hormone-, and sex-dependent manner. [europepmc]
• Mephedrone (4-methylmethcathinone) supports intravenous self-administration in Sprague-Dawley and Wistar rats. [europepmc]
• MDMA Impairs Response to Water Intake in Healthy Volunteers. [europepmc]
• Sex differences in abuse-related neurochemical and behavioral effects of 3,4-methylenedioxymethamphetamine (MDMA) in rats. [europepmc]
• The acute toxic and neurotoxic effects of 3,4-methylenedioxymethamphetamine are more pronounced in adolescent than adult mice. [europepmc]
• Docosahexaenoic acid protects motor function and increases dopamine synthesis in a rat model of Parkinson's disease via mechanisms associated with increased protein kinase activity in the striatum. [europepmc]
• Evaluation of Variability Across Rat Acute Oral Systemic Toxicity Studies. [europepmc]
• Impacts of sex differences on optogenetic, chemogenetic, and calcium-imaging tools. [europepmc]
• Balancing Therapeutic Efficacy and Safety of MDMA and Novel MDXX Analogues as Novel Treatments for Autism Spectrum Disorder. [europepmc]